Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081044 | SCV000112951 | benign | not specified | 2013-06-28 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000081044 | SCV000192854 | benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313772 | SCV000848419 | likely benign | Inborn genetic diseases | 2016-11-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000871211 | SCV001012822 | benign | Rubinstein-Taybi syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001711191 | SCV001943544 | benign | not provided | 2018-12-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001711191 | SCV002497876 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | CREBBP: BP4, BP7, BS1 |
Fulgent Genetics, |
RCV002504995 | SCV002805053 | benign | Rubinstein-Taybi syndrome due to CREBBP mutations; Menke-Hennekam syndrome 1 | 2021-07-20 | criteria provided, single submitter | clinical testing |